+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Point-of-Care Coagulation Analyzer Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6284019
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Point-of-Care Coagulation Analyzers: Executive Overview

Point-of-care coagulation analyzers provide rapid assessment of clotting function near the patient, supporting time-sensitive decisions in emergency care, surgery, trauma, cardiology, anticoagulation management, and critical care. Their value is linked to shorter testing pathways, decentralized access to results, and the ability to integrate coagulation information into broader clinical workflows. Adoption depends on analytical performance, ease of use, operator training, connectivity, quality assurance, reimbursement, and compliance with applicable medical-device requirements.

Care Delivery Is Shifting Toward Faster, Decentralized Coagulation Testing

Healthcare systems are placing greater emphasis on rapid diagnosis, procedural efficiency, and care closer to the patient. This is encouraging the use of compact analyzers in operating rooms, emergency departments, intensive-care units, ambulances, clinics, and other decentralized settings. The shift also raises expectations for standardized procedures, traceability, infection control, cartridge and consumable management, and seamless transfer of results into electronic health records. Interoperability and workflow simplicity are therefore becoming as important as analytical speed.

Artificial Intelligence Strengthens Interpretation, Workflow Control, and Quality Management

Artificial intelligence can extend the usefulness of point-of-care coagulation testing by identifying abnormal result patterns, supporting clinical decision rules, flagging inconsistent measurements, and helping prioritize repeat testing or laboratory confirmation. Machine-learning tools may also assist inventory planning, instrument maintenance, operator competency monitoring, and integration of coagulation results with medication, procedure, and patient-history data. Safe implementation requires representative validation data, transparent performance documentation, human oversight, cybersecurity controls, and safeguards against automation bias. AI should support-not replace-qualified clinical judgment and laboratory governance.

Regional Insights: Regulation, Infrastructure, and Clinical Workflow Shape Adoption

North America emphasizes rapid acute-care workflows, interoperability, accreditation, and evidence of clinical utility. Latin America presents opportunities where decentralized testing can address geographic access constraints, while procurement, training, service coverage, and budget continuity remain important considerations. Europe is shaped by harmonized regulatory expectations, quality management, cross-border clinical standards, and pressure to improve efficiency. The Middle East is investing in advanced hospital capacity and integrated care infrastructure, with demand influenced by centralized procurement and workforce capabilities. Africa has varied laboratory access and infrastructure, making ruggedness, affordability, training, and dependable support particularly relevant. Asia-Pacific combines advanced hospital systems with large and diverse care environments, creating demand for scalable deployment, localized support, connectivity, and strong quality assurance.

Group Insights: Regional Alliances Create Distinct Procurement and Compliance Contexts

ASEAN markets differ in regulatory maturity, healthcare financing, and urban-rural access, so implementation models must accommodate varied infrastructure and training needs. BRICS members span major healthcare systems with distinct procurement processes, domestic manufacturing policies, and laboratory capacities; adaptable service and evidence strategies are essential. The European Union prioritizes regulatory compliance, data governance, interoperability, and consistent quality across member states. G7 healthcare systems generally place strong emphasis on clinical validation, cybersecurity, workflow integration, and value-based procurement. GCC countries are strengthening advanced hospital services and centralized purchasing, making local partnerships, technical support, and workforce development important. NATO members encompass diverse national health systems, but emergency preparedness, trauma response, standardization, and supply resilience are recurring considerations.

Country Insights: National Health-System Characteristics Influence Deployment

Australia’s dispersed population increases the relevance of decentralized testing, telehealth connectivity, and dependable servicing. Brazil and Mexico must often balance sophisticated urban care with uneven regional access, making affordability, training, and distribution important. Canada’s geography supports solutions that perform reliably across centralized and remote settings. China is characterized by large hospital networks, expanding clinical technology capabilities, and attention to regulatory and procurement alignment. India’s varied infrastructure creates demand for simple operation, scalable training, and robust distribution. Japan and South Korea emphasize advanced hospital workflows, quality systems, and technology integration. France, Germany, Italy, and Spain operate within European regulatory frameworks while differing in procurement and hospital organization. The United Kingdom emphasizes evidence, health-system interoperability, and standardized clinical pathways. The United States has broad use across acute-care environments, with strong attention to validation, reimbursement, compliance, and integration. Russia’s deployment environment is influenced by domestic procurement, infrastructure variation, and supply continuity.

Actions for Leaders: Build Evidence, Integration, and Resilience Into Deployment

Industry leaders should validate analyzers in the specific clinical settings where they will be used, document their impact on turnaround time and decision-making, and align claims with applicable regulatory requirements. Product design should prioritize intuitive operation, specimen and consumable controls, connectivity, cybersecurity, maintenance simplicity, and clear escalation pathways to central laboratories. Commercial and implementation plans should include competency-based training, external quality assessment, service-level commitments, inventory safeguards, and regionally appropriate financing models. Leaders should also establish responsible AI governance, including bias testing, prospective monitoring, explainability, human review, and procedures for model updates. Partnerships with clinicians, laboratories, health systems, and public-sector purchasers can improve adoption while ensuring that deployment responds to measurable workflow needs.

Research Methodology: Evidence-Based Assessment of Clinical and Operational Drivers

This executive summary uses the defined point-of-care coagulation analyzer market scope and organizes findings across technology, clinical workflow, regulation, infrastructure, procurement, and implementation factors. The assessment distinguishes observed adoption drivers and barriers from forward-looking interpretation, without presenting market estimates, shares, or forecasts. Regional, group, and country perspectives are synthesized from differences in healthcare delivery, laboratory access, regulatory environments, digital infrastructure, workforce readiness, and emergency-care requirements. Artificial-intelligence considerations are evaluated through established principles of clinical validation, data governance, cybersecurity, human oversight, and quality management.

Conclusion: Clinical Utility Depends on Reliable Integration Into Care Pathways

Point-of-care coagulation analyzers are most valuable when rapid results lead to clear, evidence-based clinical action and fit within a governed testing pathway. Successful deployment requires more than compact instrumentation: it depends on analytical reliability, trained users, connectivity, quality control, supply resilience, and alignment with local regulation and reimbursement. Artificial intelligence can improve interpretation and operations when introduced cautiously and monitored continuously. Leaders that combine clinical evidence with workflow integration and region-specific implementation discipline will be better positioned to deliver dependable decentralized coagulation testing.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Point-of-Care Coagulation Analyzer Market, by Type of Product
7.1. Introduction
7.2. Portable Coagulation Analyzers
7.3. Benchtop Coagulation Analyzers
7.4. Cartridge-Based Coagulation Analyzers
7.5. Fully Automated Coagulation Analyzers
7.6. Semi-Automated Coagulation Analyzers
8. Point-of-Care Coagulation Analyzer Market, by Technology
8.1. Introduction
8.2. Photometric Technology
8.3. Impedance Technology
8.4. Clot Detection Technology
8.5. Turbidimetric Technology
8.6. Electrochemical Technology
9. Point-of-Care Coagulation Analyzer Market, by Test Type
9.1. Introduction
9.2. Prothrombin Time
9.3. International Normalized Ratio
9.4. Activated Partial Thromboplastin Time
9.5. Thrombin Time
9.6. Fibrinogen Level Testing
10. Point-of-Care Coagulation Analyzer Market, by Application
10.1. Introduction
10.2. Monitoring of Anticoagulation Therapy
10.3. Preoperative Testing
10.4. Emergency Care
10.5. Critical Care
10.6. Routine Monitoring
10.7. Hemostasis Testing
10.8. Cardiovascular Disorders
11. Point-of-Care Coagulation Analyzer Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Point-of-Care Coagulation Analyzer Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Point-of-Care Coagulation Analyzer Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Accriva Diagnostics
15.3. Amedica Corporation
15.4. Beckman Coulter, Inc.
15.5. Hemostasis, Inc.
15.6. Medtronic plc
15.7. Nova Biomedical
15.8. PTS Diagnostics
15.9. Quidel Corporation
15.10. Roche Diagnostics
15.11. Sekisui Diagnostics
15.12. Siemens Healthineers
15.13. Sysmex Corporation
15.14. Trinity Biotech
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Point-of-Care Coagulation Analyzer Market, Years Considered for the Study
FIGURE 2. Global Point-of-Care Coagulation Analyzer Market, Research Design
FIGURE 3. Global Point-of-Care Coagulation Analyzer Market, Research Framework
FIGURE 4. Global Point-of-Care Coagulation Analyzer Market, Data Triangulation
FIGURE 5. Global Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2025 vs 2032 (%)
FIGURE 7. Global Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Point-of-Care Coagulation Analyzer Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Point-of-Care Coagulation Analyzer Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 11. Global Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Point-of-Care Coagulation Analyzer Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Point-of-Care Coagulation Analyzer Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Point-of-Care Coagulation Analyzer Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Point-of-Care Coagulation Analyzer Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Point-of-Care Coagulation Analyzer Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Point-of-Care Coagulation Analyzer Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Point-of-Care Coagulation Analyzer Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Point-of-Care Coagulation Analyzer Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Point-of-Care Coagulation Analyzer Market Segmentation & Coverage
TABLE 2. Global Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 3. Global Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 4. Global Portable Coagulation Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Portable Coagulation Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Portable Coagulation Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Benchtop Coagulation Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Benchtop Coagulation Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Benchtop Coagulation Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Cartridge-Based Coagulation Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Cartridge-Based Coagulation Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Cartridge-Based Coagulation Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Fully Automated Coagulation Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Fully Automated Coagulation Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Fully Automated Coagulation Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Semi-Automated Coagulation Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Semi-Automated Coagulation Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Semi-Automated Coagulation Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 20. Global Photometric Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Photometric Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Photometric Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Impedance Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Impedance Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Impedance Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Clot Detection Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Clot Detection Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Clot Detection Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Turbidimetric Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Turbidimetric Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Turbidimetric Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Electrochemical Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Electrochemical Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Electrochemical Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 36. Global Prothrombin Time Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Prothrombin Time Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Prothrombin Time Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global International Normalized Ratio Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global International Normalized Ratio Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global International Normalized Ratio Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Activated Partial Thromboplastin Time Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Activated Partial Thromboplastin Time Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Activated Partial Thromboplastin Time Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Thrombin Time Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Thrombin Time Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Thrombin Time Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Fibrinogen Level Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Fibrinogen Level Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Fibrinogen Level Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 52. Global Monitoring of Anticoagulation Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Monitoring of Anticoagulation Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Monitoring of Anticoagulation Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Preoperative Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Preoperative Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Preoperative Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Emergency Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Emergency Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Emergency Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Critical Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Critical Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Critical Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Routine Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Routine Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Routine Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Hemostasis Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Hemostasis Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Hemostasis Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Cardiovascular Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Cardiovascular Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Cardiovascular Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Point-of-Care Coagulation Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Point-of-Care Coagulation Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. North America Point-of-Care Coagulation Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. North America Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 81. North America Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 82. North America Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 83. North America Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. Latin America Point-of-Care Coagulation Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Latin America Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 86. Latin America Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 87. Latin America Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 88. Latin America Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Europe Point-of-Care Coagulation Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Europe Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 91. Europe Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 92. Europe Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 93. Europe Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Middle East Point-of-Care Coagulation Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Middle East Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 96. Middle East Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 97. Middle East Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 98. Middle East Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. Africa Point-of-Care Coagulation Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Africa Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 101. Africa Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 102. Africa Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 103. Africa Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Global Point-of-Care Coagulation Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Point-of-Care Coagulation Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. ASEAN Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 107. ASEAN Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 108. ASEAN Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 109. ASEAN Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. GCC Point-of-Care Coagulation Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. GCC Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 112. GCC Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 113. GCC Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 114. GCC Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. European Union Point-of-Care Coagulation Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. European Union Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 117. European Union Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 118. European Union Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 119. European Union Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. BRICS Point-of-Care Coagulation Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. BRICS Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 122. BRICS Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 123. BRICS Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 124. BRICS Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. G7 Point-of-Care Coagulation Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. G7 Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 127. G7 Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 128. G7 Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 129. G7 Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. NATO Point-of-Care Coagulation Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. NATO Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 132. NATO Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 133. NATO Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 134. NATO Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. Global Point-of-Care Coagulation Analyzer Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. United States Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 137. United States Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 138. United States Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 139. United States Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 140. United States Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. Canada Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 142. Canada Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 143. Canada Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 144. Canada Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 145. Canada Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. Mexico Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 147. Mexico Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 148. Mexico Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 149. Mexico Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 150. Mexico Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Brazil Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 152. Brazil Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 153. Brazil Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. Brazil Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 155. Brazil Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. United Kingdom Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 157. United Kingdom Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 158. United Kingdom Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 159. United Kingdom Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 160. United Kingdom Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Germany Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 162. Germany Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 163. Germany Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 164. Germany Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 165. Germany Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. France Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 167. France Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 168. France Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 169. France Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 170. France Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. Russia Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 172. Russia Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 173. Russia Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 174. Russia Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 175. Russia Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Italy Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 177. Italy Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 178. Italy Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 179. Italy Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 180. Italy Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. Spain Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 182. Spain Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 183. Spain Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. Spain Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 185. Spain Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. China Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 187. China Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 188. China Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 189. China Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 190. China Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. India Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 192. India Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 193. India Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 194. India Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 195. India Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. Japan Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 197. Japan Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 198. Japan Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 199. Japan Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 200. Japan Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Australia Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 202. Australia Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 203. Australia Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 204. Australia Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 205. Australia Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. South Korea Point-of-Care Coagulation Analyzer Market Size, 2017-2032 (USD Million)
TABLE 207. South Korea Point-of-Care Coagulation Analyzer Market Size, by Type of Product, 2017-2032 (USD Million)
TABLE 208. South Korea Point-of-Care Coagulation Analyzer Market Size, by Technology, 2017-2032 (USD Million)
TABLE 209. South Korea Point-of-Care Coagulation Analyzer Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 210. South Korea Point-of-Care Coagulation Analyzer Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Global Point-of-Care Coagulation Analyzer Market Share, by Key Player, 2025
TABLE 212. Global Point-of-Care Coagulation Analyzer Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Accriva Diagnostics
  • Amedica Corporation
  • Beckman Coulter, Inc.
  • Hemostasis, Inc.
  • Medtronic plc
  • Nova Biomedical
  • PTS Diagnostics
  • Quidel Corporation
  • Roche Diagnostics
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Trinity Biotech